tradingkey.logo
搜索

AtriCure Inc

ATRC
添加自选
37.760USD
-2.390-5.95%
收盘 07-31 16:00美东报价延迟15分钟
1.92B总市值
亏损市盈率 TTM

关于 AtriCure Inc 公司

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

AtriCure Inc简介

公司代码ATRC
公司名称AtriCure Inc
上市日期Aug 05, 2005
CEOCarrel (Michael H)
员工数量1300
证券类型Ordinary Share
年结日Aug 05
公司地址7555 Innovation Way
城市MASON
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编45040
电话15137554100
网址https://www.atricure.com
公司代码ATRC
上市日期Aug 05, 2005
CEOCarrel (Michael H)

AtriCure Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
796.69K
+0.08%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
158.68K
+0.40%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
128.32K
+4.79%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
106.40K
+25.94%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
96.69K
+0.66%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
92.51K
+0.69%
Mr. Sven A. Wehrwein, CPA
Mr. Sven A. Wehrwein, CPA
Independent Director
Independent Director
40.52K
+15.16%
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
39.86K
+15.41%
Ms. Deborah H. (Deb) Telman
Ms. Deborah H. (Deb) Telman
Independent Director
Independent Director
28.33K
+21.69%
Mr. Shlomo Nachman
Mr. Shlomo Nachman
Independent Director
Independent Director
24.66K
+24.92%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
796.69K
+0.08%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
158.68K
+0.40%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
128.32K
+4.79%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
106.40K
+25.94%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
96.69K
+0.66%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
92.51K
+0.69%

常见问题

AtriCure Inc的前五大股东是谁?

AtriCure Inc 的前五大股东如下:Mr. Michael H. (Mike) Carrel, CPA

有多少机构持有AtriCure Inc(ATRC)的股份?

截至2026Q1,共有505家机构持有AtriCure Inc的股份,合计持有的股份价值约为48.18M,占公司总股份的95.14%。与2025Q4相比,机构持股有所增加,增幅为-7010307.00。

哪个业务部门对AtriCure Inc的收入贡献最大?

在2026Q1,Appendage Management-United states业务部门对AtriCure Inc的收入贡献最大,创收178.13M,占总收入的33.32%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有